| Application no. and date | 17718560.0 (espacenet) (Federated) (European Patent Register), 20170425 | | Patent/reg. no. and date | DK/EP 3448848, 20230927 | | Publication date | 20190306 | | Priority no. and date | EP 16167652, 20160429 | | EP pub. no. and date |
EP 3448848 20190306 | | Effective date | | | Applicant/owner | Bayer Pharma Aktiengesellschaft, Müllerstrasse 178
13353 Berlin, DE | | Applicant ref. no. | 1675064 | | Inventor | THALER, Tobias, Prälat-Van-Acken-Str. 1
50935 Köln, DE,
PLATZEK, Johannes, Grottkauer StraÃYe 55
12621 Berlin, DE,
GUIMOND, Nicolas, Katernberger StraÃYe 126
42115 Wuppertal, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/4439 (2006.01) , A61P 27/00 (2006.01) , A61P 35/00 (2006.01) , A61P 37/00 (2006.01) , A61P 9/00 (2006.01) , C07D 401/12 (2006.01) | | Title | POLYMORF FORM AF N-{6-(2-HYDROXYPROPAN-2-YL)-2-[2-(METHYLSULPHONYL)ETHYL]-2H-INDAZOL-5-YL}-6-(TRIFLUORMETHYL)PYRIDIN-2-CARBOXAMID | | Int. application no. | EP2017059767 | | Int. publication no. | WO2017186703 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
